Developer docs
API playgroundTry for free, no card

Search company profiles

Steth IO

Full company profile

uuid0003t7b

Namestring
Steth IO
Legal namestring
StratoScientific, Inc.
Websiteurl
stethio.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Steth IO (legal entity StratoScientific, Inc.) is a Bothell, Washington-based medical device and software company that develops a smartphone-compatible digital stethoscope (Spot) and a telemedicine platform enabling remote cardiopulmonary examination. The Spot device connects to a patient's smartphone to capture heart and lung sounds, which are then transmitted over a cloud platform and displayed visually to providers during live audio-visual telemedicine visits — intended to give clinicians diagnostic information comparable to in-person auscultation. The platform also operates under the Telaspot sub-brand, which bundles scheduling, messaging, remote patient monitoring, and one-click virtual-clinic deployment into a customizable branded environment for healthcare providers.

The company's technology stack rests on an acoustic collection system protected by multiple granted US utility patents (with parallel design and utility filings in China, Japan, Canada, and the EU) covering the smartphone-coupled stethoscope form factor and a visual sound-representation interface. Steth IO monetizes through a mix of one-time hardware sales of the Spot device, recurring software subscriptions to its telemedicine platform (with customized pricing for providers and health systems), and in-app purchases for additional features. Distribution is multi-modal: direct enterprise sales to healthcare institutions, a self-serve PLG motion through Telaspot for small practices, and an embedded app within Cisco Webex (announced May 2024) that leverages Webex's enterprise collaboration install base.

The company was founded in 2015 by interventional cardiologist Dr. Mahesh Mulumudi and technology veteran Dr. Craig Rosenberg, with operational leadership including COO Avani Vimawala and VP of Strategy Jess Corrick. Steth IO has raised approximately $1.9M in disclosed funding across 2015, 2018, and 2020 (the last being a Newchip Accelerator participation), employs 1-10 people, and serves US-based healthcare providers, small practices, large health systems, payers, and chronic-condition patients as its primary customer segments. No institutional venture rounds have been disclosed since 2018, and no public revenue figures are available.

Short descriptiontext

Steth IO builds a smartphone-connected digital stethoscope (Spot) and a telemedicine platform that lets healthcare providers capture, visualize, and diagnose heart and lung sounds during remote audio-visual visits, serving US providers, practices, health systems, and chronic-care patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBothell, United States
HQ citystring
Bothell
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote patient monitoring, digital stethoscope technology, telemedicine platform, cardiopulmonary examination software, connected medical devices
Industry4 codes
PRIMARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAJAL
Urgent Care + ePrescribing & Lab/Imaging Ordering Telehealth Platforms
Healthcare & Life Sciences/Telehealth Platforms/Urgent Care & On-Demand Triage Telehealth Platforms
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
  • Communications Equipment, Nec3669
Product category
Telemedicine and Remote Patient Monitoring
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware Device Sales (Spot)
TypeHardware Sales
Description

Sale of the Steth IO Spot digital stethoscope device that connects to smartphones for capturing heart and lung sounds. The device is shipped directly to patients' homes within four days of ordering.

stethio.com
2Software Platform Subscription
TypeSubscription Recurring
Description

Telemedicine platform subscription for healthcare institutions to enroll clinical staff, patients, and access the central repository of securely collected clinical information during clinical care. EULA mentions in-app purchases for additional features.

stethio.com
3In-App Purchases
TypeOne Time License
Description

Additional features or functionality available for purchase through the application, including premium capabilities within the platform.

stethio.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
Pricing details2 tiers
1Customized platform pricing for providers and clinics
ModelSubscriptionBilling cadenceAnnual
Notes

The Telaspot platform offers customized pricing to meet providers and clinics where they are at, with scalable pricing for small practices and large health systems alike.

stethio.com
2Connected device (Spot stethoscope)
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

Connected devices typically cost upwards of $300 in the market. Steth IO positions its solution as more affordable compared to similar devices and platforms while maintaining full remote examination capabilities.

stethio.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Telaspot
Description

A telehealth, remote patient monitoring, and communication platform by Steth IO that provides next-generation telemedicine with all-in-one capabilities including scheduling patient visits, audio-visual calls with device-enabled diagnostic capabilities, messaging between patients and physicians, and remote patient monitoring.

stethio.com
Core offering1 text field

Steth IO develops and sells a smartphone-compatible digital stethoscope device (Spot) paired with a cloud-based telemedicine platform that enables healthcare providers to conduct remote cardiopulmonary examinations during live audio-visual visits. The platform visually represents heart and lung sounds captured by the connected device, allowing physicians to diagnose abnormalities with greater accuracy than traditional telemedicine. The Telaspot continuous care platform extends this with integrated scheduling, messaging, and remote patient monitoring capabilities for healthcare institutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Reduced telemedicine implementation time from 16-24 months to one-click deployment
+4 more records
Product overview1 text field

Steth IO offers a telemedicine platform architecture consisting of a core software platform (Steth IO Platform) combined with a hardware device (Steth IO Spot) that captures heart and lung sounds via smartphone. The platform integrates with the Telaspot sub-brand for scalable continuous care management including scheduling, messaging, and RPM. The Steth IO Spot is a smartphone-compatible digital stethoscope that plugs into patients' phones to capture auscultation data which is then transmitted and displayed visually to providers during live telemedicine visits. An embedded app version for Cisco Webex extends the platform's availability within enterprise collaboration environments. Together these components enable remote cardiopulmonary examination that rivals in-person clinical visits by combining live audio-visual communication with device-enabled diagnostic data capture and visualization.

Product and service3 records
1Steth IO Platform
CategoryTelemedicine software platform
Description

A next-generation telemedicine platform providing remote patient monitoring and telehealth capabilities. It enables healthcare providers to conduct audio-visual remote visits with patients while capturing and visualizing heart and lung sounds via a connected device, making remote examinations comparable to in-person clinical visits.

2Steth IO Spot Digital Stethoscope
CategoryConnected medical device (hardware)
Description

A smartphone-compatible digital stethoscope device that plugs directly into a patient's smartphone to capture heart and lung sounds. The captured audio signals are transmitted to the provider during telemedicine visits and displayed visually on the provider screen for enhanced diagnostic accuracy.

3Telaspot by Steth IO
CategoryRemote patient monitoring and continuous care platform
Description

A scalable continuous care platform that combines telemedicine visits, scheduling, messaging between patients and physicians, and remote patient monitoring in one unified system. The platform can be customized and branded for individual clinics and healthcare organizations, with one-click implementation allowing providers to launch their virtual clinic and enroll patients within minutes.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-05-01
Description

Steth IO has partnered with Cisco Webex to embed its telemedicine application directly within the Webex collaboration platform. The Steth IO telemedicine system provides next-generation telemedicine capabilities through a hybrid audio-visual examination platform and connected device that captures heart and lung sounds. With these augmented telemedicine capacities, Steth IO empowers telemedicine providers to offer greater accuracy and a smoother exam experience comparable clinically to an in-person visit. Webex believes the future of work is hybrid and is enabling app partners to deliver unique workflows directly within the Webex experience through Embedded Apps.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Vivify Health provides a connected-health RPM platform used by health systems and payers to manage chronic conditions including CHF and COPD. It overlaps with Steth IO's Telaspot continuous-care positioning for chronic-disease monitoring at home.

TypeBroad incumbent
Description

Amwell is a major enterprise telehealth platform with deep health-system integrations and a connected-device program. It competes with Steth IO's Telaspot platform at the provider-software layer, particularly for organizations that prefer to buy telehealth through a single incumbent vendor.

TypeBroad incumbent
Description

Doximity's Dialer and telehealth tools are widely adopted by US physicians for simple virtual visits. While Doximity does not offer auscultation hardware, it sets the baseline expectation for physician-facing telemedicine UX that Steth IO's Telaspot must exceed to drive adoption.

TypeDirect peer
Description

AliveCor makes the KardiaMobile personal ECG device and a clinician AI-ECG platform. It is directly comparable to Steth IO in the consumer-and-clinician cardiac diagnostics category, with stronger consumer brand recognition but a narrower (ECG-only) signal set than Steth IO's heart-and-lung auscultation.

TypeBroad incumbent
Description

Teladoc Health is a large publicly-traded telehealth platform with enterprise health-system contracts across multiple specialties. While not a hardware peer, it competes for the same provider budget and patient visits and limits Steth IO's ability to upsell stand-alone device-led RPM.

TypeDirect peer
Description

Eko Health manufactures the CORE digital stethoscope and a telehealth/AI platform that analyzes heart and lung sounds. It is the closest direct competitor to Steth IO's Spot device and visual-audio auscultation platform, with far greater capital, FDA clearances, and provider adoption.

TypeEmerging player
Description

Heartbeat Health is a virtual cardiology practice and RPM platform for patients with heart failure and arrhythmias. It is comparable to Steth IO as a competitor for cardiology-specific telehealth and remote cardiac monitoring budgets, though it is a services-led model rather than a hardware one.

TypeDirect peer
Description

TytoCare offers a handheld remote examination device paired with a telehealth platform for guided home exams of heart, lung, throat, skin, and ears. It is directly comparable to Steth IO's Spot + Telaspot combination, particularly for primary care and chronic-condition RPM use cases.

TypeDirect peer
Description

iRhythm makes the Zio wearable cardiac monitoring patch and an AI-based ECG analysis service. It is comparable to Steth IO in the cardiac RPM niche, although it focuses on longer-duration ambulatory ECG monitoring rather than point-of-care auscultation.

TypeBroad incumbent
Description

3M Littmann is the dominant traditional stethoscope brand and, through Solventum and Eko partnerships, is expanding into digital/connected auscultation. It represents the broad incumbent that providers default to and against which Steth IO must differentiate on digital-native capabilities.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Steth IO

Telemedicine and Remote Patient Monitoringstethio.com

Steth IO builds a smartphone-connected digital stethoscope (Spot) and a telemedicine platform that lets healthcare providers capture, visualize, and diagnose heart and lung sounds during remote audio-visual visits, serving US providers, practices, health systems, and chronic-care patients.

What Steth IO does

Steth IO (legal entity StratoScientific, Inc.) is a Bothell, Washington-based medical device and software company that develops a smartphone-compatible digital stethoscope (Spot) and a telemedicine platform enabling remote cardiopulmonary examination. The Spot device connects to a patient's smartphone to capture heart and lung sounds, which are then transmitted over a cloud platform and displayed visually to providers during live audio-visual telemedicine visits — intended to give clinicians diagnostic information comparable to in-person auscultation. The platform also operates under the Telaspot sub-brand, which bundles scheduling, messaging, remote patient monitoring, and one-click virtual-clinic deployment into a customizable branded environment for healthcare providers.

The company's technology stack rests on an acoustic collection system protected by multiple granted US utility patents (with parallel design and utility filings in China, Japan, Canada, and the EU) covering the smartphone-coupled stethoscope form factor and a visual sound-representation interface. Steth IO monetizes through a mix of one-time hardware sales of the Spot device, recurring software subscriptions to its telemedicine platform (with customized pricing for providers and health systems), and in-app purchases for additional features. Distribution is multi-modal: direct enterprise sales to healthcare institutions, a self-serve PLG motion through Telaspot for small practices, and an embedded app within Cisco Webex (announced May 2024) that leverages Webex's enterprise collaboration install base.

The company was founded in 2015 by interventional cardiologist Dr. Mahesh Mulumudi and technology veteran Dr. Craig Rosenberg, with operational leadership including COO Avani Vimawala and VP of Strategy Jess Corrick. Steth IO has raised approximately $1.9M in disclosed funding across 2015, 2018, and 2020 (the last being a Newchip Accelerator participation), employs 1-10 people, and serves US-based healthcare providers, small practices, large health systems, payers, and chronic-condition patients as its primary customer segments. No institutional venture rounds have been disclosed since 2018, and no public revenue figures are available.

Steth IO firmographics

Firmographics
Name
Steth IO
Legal name
StratoScientific, Inc.
Website
https://stethio.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
Steth IO builds a smartphone-connected digital stethoscope (Spot) and a telemedicine platform that lets healthcare providers capture, visualize, and diagnose heart and lung sounds during remote audio-visual visits, serving US providers, practices, health systems, and chronic-care patients.
Ownership category
akta.pro rank

Steth IO industry classification

Industry
Product category
Telemedicine and Remote Patient Monitoring
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Communications Equipment, Nec (3669)
akta.pro industry
PRIMARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAJAL
Urgent Care + ePrescribing & Lab/Imaging Ordering Telehealth Platforms
Healthcare & Life Sciences/Telehealth Platforms/Urgent Care & On-Demand Triage Telehealth Platforms

Keywords

  • Remote patient monitoring
  • Digital stethoscope technology
  • Telemedicine platform
  • Cardiopulmonary examination software
  • Connected medical devices

Where Steth IO is headquartered

Location

Headquarters

HQ city
Bothell
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Steth IO business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Hardware Device Sales (Spot): Sale of the Steth IO Spot digital stethoscope device that connects to smartphones for capturing heart and lung sounds. The device is shipped directly to patients' homes within four days of ordering.
  2. Software Platform Subscription: Telemedicine platform subscription for healthcare institutions to enroll clinical staff, patients, and access the central repository of securely collected clinical information during clinical care. EULA mentions in-app purchases for additional features.
  3. In-App Purchases: Additional features or functionality available for purchase through the application, including premium capabilities within the platform.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualCustomized platform pricing for providers and clinics
Unit PricingOne time/ perpetual licenseConnected device (Spot stethoscope)

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Steth IO product offering

Product offering

Core offering

Steth IO develops and sells a smartphone-compatible digital stethoscope device (Spot) paired with a cloud-based telemedicine platform that enables healthcare providers to conduct remote cardiopulmonary examinations during live audio-visual visits. The platform visually represents heart and lung sounds captured by the connected device, allowing physicians to diagnose abnormalities with greater accuracy than traditional telemedicine. The Telaspot continuous care platform extends this with integrated scheduling, messaging, and remote patient monitoring capabilities for healthcare institutions.

Product overview

Steth IO offers a telemedicine platform architecture consisting of a core software platform (Steth IO Platform) combined with a hardware device (Steth IO Spot) that captures heart and lung sounds via smartphone. The platform integrates with the Telaspot sub-brand for scalable continuous care management including scheduling, messaging, and RPM. The Steth IO Spot is a smartphone-compatible digital stethoscope that plugs into patients' phones to capture auscultation data which is then transmitted and displayed visually to providers during live telemedicine visits. An embedded app version for Cisco Webex extends the platform's availability within enterprise collaboration environments. Together these components enable remote cardiopulmonary examination that rivals in-person clinical visits by combining live audio-visual communication with device-enabled diagnostic data capture and visualization.

Differentiator

Problem solved

Functional benefit

Brands

  • Telaspot: A telehealth, remote patient monitoring, and communication platform by Steth IO that provides next-generation telemedicine with all-in-one capabilities including scheduling patient visits, audio-visual calls with device-enabled diagnostic capabilities, messaging between patients and physicians, and remote patient monitoring.

Products and services

  • Steth IO Platform A next-generation telemedicine platform providing remote patient monitoring and telehealth capabilities. It enables healthcare providers to conduct audio-visual remote visits with patients while capturing and visualizing heart and lung sounds via a connected device, making remote examinations comparable to in-person clinical visits.
  • Steth IO Spot Digital Stethoscope A smartphone-compatible digital stethoscope device that plugs directly into a patient's smartphone to capture heart and lung sounds. The captured audio signals are transmitted to the provider during telemedicine visits and displayed visually on the provider screen for enhanced diagnostic accuracy.
  • Telaspot by Steth IO A scalable continuous care platform that combines telemedicine visits, scheduling, messaging between patients and physicians, and remote patient monitoring in one unified system. The platform can be customized and branded for individual clinics and healthcare organizations, with one-click implementation allowing providers to launch their virtual clinic and enroll patients within minutes.

Quantifiable outcome

  • Reduced telemedicine implementation time from 16-24 months to one-click deployment
  • +4 more outcomes

Companies that use Steth IO

Customer profile

Segments4 records

Ideal customer profiles3 records

Steth IO technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability5 records

Feature4 records

Steth IO partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Webex by CiscocoreTechnology or Integration · 1 May 2024Steth IO has partnered with Cisco Webex to embed its telemedicine application directly within the Webex collaboration platform. The Steth IO telemedicine system provides next-generation telemedicine capabilities through a hybrid audio-visual examination platform and connected device that captures heart and lung sounds. With these augmented telemedicine capacities, Steth IO empowers telemedicine providers to offer greater accuracy and a smoother exam experience comparable clinically to an in-person visit. Webex believes the future of work is hybrid and is enabling app partners to deliver unique workflows directly within the Webex experience through Embedded Apps.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Steth IO competitors and assessment

Company assessment

Direct peers

  • Vivify Health: Vivify Health provides a connected-health RPM platform used by health systems and payers to manage chronic conditions including CHF and COPD. It overlaps with Steth IO's Telaspot continuous-care positioning for chronic-disease monitoring at home.
  • AliveCor: AliveCor makes the KardiaMobile personal ECG device and a clinician AI-ECG platform. It is directly comparable to Steth IO in the consumer-and-clinician cardiac diagnostics category, with stronger consumer brand recognition but a narrower (ECG-only) signal set than Steth IO's heart-and-lung auscultation.
  • Eko Health: Eko Health manufactures the CORE digital stethoscope and a telehealth/AI platform that analyzes heart and lung sounds. It is the closest direct competitor to Steth IO's Spot device and visual-audio auscultation platform, with far greater capital, FDA clearances, and provider adoption.
  • TytoCare: TytoCare offers a handheld remote examination device paired with a telehealth platform for guided home exams of heart, lung, throat, skin, and ears. It is directly comparable to Steth IO's Spot + Telaspot combination, particularly for primary care and chronic-condition RPM use cases.
  • iRhythm Technologies: iRhythm makes the Zio wearable cardiac monitoring patch and an AI-based ECG analysis service. It is comparable to Steth IO in the cardiac RPM niche, although it focuses on longer-duration ambulatory ECG monitoring rather than point-of-care auscultation.

Broad incumbents

  • Amwell: Amwell is a major enterprise telehealth platform with deep health-system integrations and a connected-device program. It competes with Steth IO's Telaspot platform at the provider-software layer, particularly for organizations that prefer to buy telehealth through a single incumbent vendor.
  • Doximity: Doximity's Dialer and telehealth tools are widely adopted by US physicians for simple virtual visits. While Doximity does not offer auscultation hardware, it sets the baseline expectation for physician-facing telemedicine UX that Steth IO's Telaspot must exceed to drive adoption.
  • Teladoc Health: Teladoc Health is a large publicly-traded telehealth platform with enterprise health-system contracts across multiple specialties. While not a hardware peer, it competes for the same provider budget and patient visits and limits Steth IO's ability to upsell stand-alone device-led RPM.
  • 3M Littmann (Solventum): 3M Littmann is the dominant traditional stethoscope brand and, through Solventum and Eko partnerships, is expanding into digital/connected auscultation. It represents the broad incumbent that providers default to and against which Steth IO must differentiate on digital-native capabilities.

Emerging players

  • Heartbeat Health: Heartbeat Health is a virtual cardiology practice and RPM platform for patients with heart failure and arrhythmias. It is comparable to Steth IO as a competitor for cardiology-specific telehealth and remote cardiac monitoring budgets, though it is a services-led model rather than a hardware one.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Steth IO social profiles

Digital presence

Steth IO compliance and trust

Trust signal

Compliance1 record

Steth IO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Steth IO leadership team

Management profile

Number of profiles

Profiles1 record

Steth IO funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Steth IO M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Steth IO

What does Steth IO do?

Steth IO develops and sells a smartphone-compatible digital stethoscope device (Spot) paired with a cloud-based telemedicine platform that enables healthcare providers to conduct remote cardiopulmonary examinations during live audio-visual visits. The platform visually represents heart and lung sounds captured by the connected device, allowing physicians to diagnose abnormalities with greater accuracy than traditional telemedicine. The Telaspot continuous care platform extends this with integrated scheduling, messaging, and remote patient monitoring capabilities for healthcare institutions.

Is Steth IO a public or private company?

Steth IO is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Steth IO founded?

Steth IO was founded in 2015. It employs 1 to 10 people.

Where is Steth IO based?

Steth IO is headquartered in Bothell, United States, in the North America region.

How does Steth IO make money?

Three revenue lines are on record. Hardware Device Sales (Spot) is the primary driver. The others are software Platform Subscription and in-App Purchases.

Who are Steth IO's main competitors?

Direct peers on record are Vivify Health, AliveCor, Eko Health, TytoCare and iRhythm Technologies. Broad incumbents are Amwell, Doximity, Teladoc Health and 3M Littmann (Solventum). Heartbeat Health is listed as an emerging player.

Does Steth IO have an API?

No public API is recorded for Steth IO.

What industry is Steth IO in?

Steth IO's product category is Telemedicine and Remote Patient Monitoring. Its primary akta.pro industry code is HLALAGAB, Cardiology Telemedicine Platforms, with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals